The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 58 | 0.7x | 20.1x | Near average | |
Growth | 56 | -24.4% | 5.6% | Near average | |
Quality | 30 | -48.0% | 7.6% | Below average | |
Safety | 36 | -0.3x | 0.4x | Near average | |
Capital Return | 14 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
DarioHealth Corp. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy DarioHealth Corp. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
DarioHealth stock shows complete stability in the average price target at 12.5 dollars over the past 7 and 30-day periods, without recording any adjustments by analysts. This consistency reflects the absence of new catalysts or updated financial data that might prompt a re-evaluation, noting that the current price (7.86) is trading near the lower end of the target range (7.5).
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.